Gynae

Recurrent Urinary Tract Infections in Menopause

Creator: Dr Nadira Awal
Published: 2026-01-15

Why UTIs rise after menopause — and why vaginal oestrogen prevents them.

By Dr Nadira AwalBMS Specialist2 min readMedically reviewed 9 July 2026

Tall glass of water with lemon and a small dish of cranberries

Falling oestrogen thins the urinary tract lining and shifts vaginal pH. Vaginal oestrogen is the single most effective preventer, backed by robust UK evidence.

Recurrent urinary tract infections are one of the most under-recognised menopausal problems. In UK primary care they are often treated as a series of unrelated infections, with rotating short courses of antibiotics — when in fact, in postmenopausal women, the underlying driver is almost always oestrogen deficiency in the urogenital tissues. Correcting that with vaginal oestrogen prevents UTIs more effectively than long-term preventive antibiotics in randomised trials, and does so without contributing to antimicrobial resistance. This is one of the highest-value, lowest-risk interventions in menopause medicine.

Why UTIs rise after menopause

Falling oestrogen thins the lining of the bladder, urethra and vagina, making it easier for bacteria to adhere and invade.
The vaginal microbiome shifts away from protective lactobacilli and towards higher-pH, coliform-friendly flora.
Pelvic floor weakness, prolapse and incomplete bladder emptying leave residual urine that becomes a reservoir for bacteria.
Local oestrogen deficiency is part of Genitourinary Syndrome of Menopause (GSM) — dryness, discomfort and recurrent UTIs are three faces of the same problem.

First-line treatment: vaginal oestrogen

Estriol cream (Ovestin, Blissel), estradiol tablets (Vagifem, Vagirux) or the estradiol ring (Estring) all work well — patient preference guides choice.
Typical regimen: nightly for 2 weeks, then twice weekly indefinitely — effect builds over 4–12 weeks.
Systemic absorption is minimal — vaginal oestrogen is safe long-term for the majority of women, including many with a personal history of breast cancer after oncology review.
Effect is maintained only while it is being used — stopping means symptoms return.

Supporting measures with reasonable evidence

D-mannose 2g daily reduces recurrence in several small trials; safe and inexpensive.
Cranberry extract (concentrated tablets, not juice) has a modest preventive effect in some women.
Hydration to a pale-straw urine colour and treating constipation both matter.
Vaginal probiotics containing L. crispatus or L. rhamnosus have emerging supportive evidence.

When to investigate further

3 or more culture-confirmed UTIs in 12 months, or 2 in 6 months, warrant urology or menopause specialist review.
Visible blood in urine, flank pain, fever/rigors or vomiting suggests upper-tract infection — same-day medical review.
An ultrasound scan and post-void residual measurement rule out stones, poor emptying and structural causes.

Everyday habits that help a little

Wipe front to back, urinate soon after sex, avoid perfumed washes, bath additives and douches.
Cotton underwear and loose clothing keep the area drier.
Address vaginal dryness proactively with moisturisers alongside oestrogen — comfort at rest matters, not just at intimacy.

When antibiotics are still needed

Confirmed acute infections should be treated with a short, targeted course based on urine culture.
Long-term low-dose prophylactic antibiotics are a last resort — they drive resistance and rarely outperform vaginal oestrogen.

Key takeaway

Recurrent UTIs after menopause are usually a hormone problem, not just an infection problem — vaginal oestrogen is often the missing treatment.

How Dr Awal approaches this in clinic

Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.

A detailed 60 minute first appointment — no rushed 10-minute slots.
Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
Body-identical HRT considered first-line where appropriate.
Shared-care letters sent to your NHS GP so treatment can continue affordably.
Follow-up at 3 months to fine-tune your regimen and address side effects.
Ongoing annual reviews so your plan evolves with you.

Common questions we hear about this

Do I need to be at a certain age to be seen?

No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.

Will my GP continue the prescription?

In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.

What if I've tried HRT before and it didn't suit me?

Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.

How long will I need to stay on treatment?

There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.

Where do you see patients?

All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.

About the author

Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.

Sources & further reading

General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.

Talk it through